Fri.Jul 22, 2022

article thumbnail

Biopharma has a brand new target: Cancer-specific collagen

MedCity News

Researchers at the University of Texas MD Anderson Cancer Center published a new study revealing that cancer cells make their own unique form of collagen to help them grown and proliferate. This means drug developers may have a new, highly specific target for oncology therapeutics.

Biopharma 113
article thumbnail

ASRS conference reveals hopeful outcomes for gene therapy RGX-314 in retinal diseases

Pharmaceutical Technology

Pipeline therapies within the diabetic macular oedema (DME) space have recently gathered interest following the American Society of Retina Specialists (ASRS) Annual Meeting, which took place on 13–16 July. The spotlight was placed on many up-and-coming pharmacotherapies for retinal diseases, one of which was AbbVie’s/Regenxbio’s gene therapy RGX-314.

Patients 104
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Is the HIF-PHI class of next-generation kidney drugs doomed in the U.S.?

MedCity News

Kidney disease patients need access to innovative therapies to expand treatment choices and improve quality of life. The FDA should closely examine whether it is applying the appropriate benefit/risk assessment for new drugs intended for this population.

FDA 107
article thumbnail

Pfizer, Flynn fined £70m in resurrected epilepsy drug pricing probe

pharmaphorum

Drugmakers Pfizer and Flynn Pharma have been fined £70 million ($84 million) by the UK Competition and Markets Authority (CMA) for overcharging the NHS for a widely-used epilepsy drug. The CMA delivered a preliminary judgment in the case last year which concluded that Pfizer and Flynn abused a dominant position in phenytoin sodium capsules, causing NHS spending on the drug to balloon from around £2 million a year in 2012 to £50 million the following year.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

8 Ultimate Ways To Market Your Virtual Assistant Business

Medico Reach

If you own a virtual assistant business, then you are one of the only businesses that did well in the pandemic. Thanks to the onset of the COVID-19 virus, the adoption of remote work and virtual assistants saw a significant uptick. A certain study also states that hiring virtual assistants can help you save up to 78% of the operating cost value. On an average, this amounts to a U.S. employer saving around USD 11,000 in hiring costs by opting for a remote workforce.

article thumbnail

Largest-Ever Industry Report Reveals Video Meetings 3x More Effective and Companies Using Them Most Gain Advantage

PharmExec

Data from over 130 million quarterly HCP-field interactions across 80% of global biotech and pharma companies unveiled in Veeva Pulse Field Trends Report - industrywide data shows frequent use of key digital channels is vital for effective HCP engagement.

Pharma 98

More Trending

article thumbnail

Virtual mental health increasingly important for younger and Hispanic populations, data shows

MedCity News

While 92% of consumers said virtual care adds convenience when choosing a primary care provider, those accessing virtual mental healthcare had different responses to how convenient/private it was based on age and race, CVS Health data showed. .

article thumbnail

Amazon ratchets up its health ambitions, buying US primary care group

pharmaphorum

Amazon has accelerated its expansion into the healthcare sector with an all-cash deal to acquire One Medical, a US group that provides virtual and in-person primary care services using a subscription fee model. Amazon is buying One Medical for $18 per share, valuing the company at around $3.9 billion and making it one of the online retail giant’s largest-ever acquisitions – and by far its biggest within the health category.

Medical 99
article thumbnail

6 review and approval software implementation best practices

Vodori

Implementing review and approval software often comes with a stigma that it takes forever, is full of challenges and barriers, and requires a significant amount of time and effort from your team. While that may be true for some software implementations, at Vodori, we have devised a review and approval software implementation process that is simple, streamlined, and built on a foundation of industry knowledge.

article thumbnail

NICE recommends Rhythm’s Imcivree to help treat obesity and control hunger

PharmaTimes

The treatment has been developed for people aged six years and over will be available for use across the NHS

105
105
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

The new European Unitary Patent system – What you need to know

pharmaphorum

The proposed European unitary patent and unified patent court represents one of the largest changes to the European patent system in a generation. It will usher in a new European patent right (the unitary patent) which will have unitary effect across participating member states. A new court system (the unified patent court or UPC) will also be established to handle litigation not only of the new unitary patents, but also of European patents under the current system that are validated nationally

article thumbnail

StartUPDATES: New developments from healthcare startups

MedCity News

Check out news from Carrum Health, BigHat Biosciences, YourChoice Therapeutics, and more.

article thumbnail

US Prepares To Take On Penguin, S&S Merger

Copyright Clearance Center

The post US Prepares To Take On Penguin, S&S Merger appeared first on Copyright Clearance Center.

95
article thumbnail

Vicebio targets development of novel vaccines

PharmaTimes

Molecular clamp technology is a protein tag that stabilises a wide range of complex viral proteins

91
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

EC approves amendment of Valneva’s Covid-19 vaccines purchase deal

Pharmaceutical Technology

The European Commission (EC) has approved an advance purchase agreement (APA) amendment for Valneva’s inactivated whole-virus Covid-19 vaccine, VLA2001. The latest move follows remediation discussions based on the notice sent to the company regarding the termination of the initial APA for purchasing vaccine doses this year and the optional doses for next year.

article thumbnail

Review Finds No Link Between Serotonin Levels, Chemical Imbalance and Depression

Pharmacy Times

A review of decades of research concluded that there is no evidence of an association between serotonin levels and depression, calling the function of antidepressants into question.

65
article thumbnail

Why You Need to Diversify Your Hiring Process

Rep-Lite

A medical and pharmaceutical company can face a lot of demand in today's world. Businesses in these fields need to form strong teams of sales representatives and experts to keep hitting high pharmaceutical and medical sales. Pharmaceutical sales reps may struggle to reach the quota if their team lacks members. Aside from ensuring that your business has the correct number of employees, it is also essential to ensure that your company's hiring process is free from biases.

Sales 52
article thumbnail

3 Ways to Use a Mobile Sales Tool Outside of the Pitch

Modus

A mobile sales tool can help your salespeople stay organized, on-message, up-to-date, and even appear more professional. But, a good sales tool enables users to leverage it outside of the pitch. Mobile is an investment, so it’s important to know that while sales enablement is the primary function of a mobile sales tool, the right app will go far beyond the pitch.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

3 Reasons Storyvine is perfect for Healthcare Companies

Storyvine

Storyvine Sales Manager Rich Ryan explains the top reasons why Storyvine is perfect for the healthcare space. 1. Video at Scale. Whether you’re a fortune 500 company or a small non-profit, you have incredible stories to tell. With Storyvine’s guided capture and automated editing you have a limitless ability to capture videos at a fraction of the cost of traditional video. 2.

article thumbnail

Lower Carbon Readiness: How to Verify Organizational Buy-In

ALULA

Video discussion with John Dale, Global Energy Practice Lead and Krystyna Riley, Strategic Accounts Leader. If you’re leading a decarbonization/net-zero initiative, then you’re utilizing influence skills all the time. So, how can you confirm whether your efforts are paying off? When an overall transformation is both unprecedented and long-term, and the teams involved are variable, it’s hard to know where to look for a sign that everyone’s on board.

Leads 52
article thumbnail

MedicoReach Succeed Medical Device Manufacturing Company To Reach Hospitals And Increased ROI 100%

Medico Reach

About the Client. Our team recently assisted a client in achieving better sales and connecting to more customers via our healthcare data services. The client is a medical device manufacturing organization producing high-quality surgical equipment and medical tools. They design and market these devices to various healthcare facilities. Our client manufactures products, including orthopedic instruments, diagnostic apparatus, cardiovascular equipment, dental devices, and diabetic tools.

article thumbnail

ARS Pharmaceuticals to merge with Silverback Therapeutics

Pharmaceutical Technology

ARS Pharmaceuticals has signed a definitive agreement to merge with Silverback Therapeutics in an all-stock transaction. The combined company will operate under the name ARS Pharmaceuticals and be headquartered in San Diego, California, US, after the completion of the transaction. It will focus on the potential regulatory clearance and commercialisation of ARS’ investigational epinephrine nasal spray, neffy.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

2nd Annual Next Generation Pharmaceutical Cleanrooms Conference

pharmaphorum

Sponsored by Ecolab, Elis Cleanroom, Innerspace, Microgenetics, Novatek. Co-Chaired by: Conor Murray, Chairman, Irish Cleanroom Society and Connor McMorrow, Aseptic Lead Cell Therapy, Takeda. Advances in Pharma 4.0 for an Improved, Efficient and Contaminant-Free Cleanroom. [link]. SAE Media Group are pleased to announce the 2nd Annual Next Generation Pharmaceutical Cleanroom Conference.

article thumbnail

Top tweets: Covid-19 headed towards seasonality – and more

Pharmaceutical Technology

Pharmaceutical Technology lists five of the top tweets on infectious diseases in Q2 2022 based on data from GlobalData’s Pharmaceuticals Influencer Platform. The top tweets are based on total engagements (likes and retweets) received on tweets from more than 188 infectious diseases experts tracked by GlobalData’s Pharmaceuticals Influencer platform during the second quarter (Q2) of 2022.

article thumbnail

Report finds UK risks falling behind rivals in life sciences

pharmaphorum

A just-published report on the UK’s life sciences sector “ought to ring alarm bells across government,” according to the Association of the British Pharmaceutical Industry (SBPI). The Life Sciences Competitiveness Indicators report shows that spending on life sciences R&D was £2.7 billion in 2020 – accounting for 0.12% of GDP and ranked third among the top 15 industrialised nations, behind only the US and Japan.

article thumbnail

E???????????????? ?????????? ????????-???? ?????????? ???? ?????????????????? ???? ???????? ????, ????????

Pharma Pathway

To achieve our DEI goals, we have refined our policies and increased career opportunities for women through several initiatives that also include ‘Diversity Hiring’. ?????????? ???????? ????????????????????, ???? ???????? ?????????????????? ???? ?????????????????? ?????????? ????????-???? ?????????? ???? ?????????????????? ???? ???????? ????, ????????.

52
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Oncoustics raises $5.5m for ‘virtual biopsy’ AI platform

pharmaphorum

Digital health startup Oncoustics has raised $5.5 million in seed funding to develop an artificial intelligence-powered technology that will be used to spot and diagnose liver diseases from ultrasound images. The new company – based in Toronto and San Francisco – will use the new funding to accelerate the development of its lead software-as-a-medical device (SaMD) OnX, used to detect changes like scaring (fibrosis) and fatty build-up (steatosis) in chronic liver diseases.

Medical 52
article thumbnail

The Case for Market Access.Early and Often

PharmExec

Industry veteran Ken Abreu makes the case for approaching market access very early in the process, and elucidates why it's so important.

article thumbnail

Daily Medication Pearl: Privigen Immune Globulin Intravenous (Human)

Pharmacy Times

Privigen is indicated for the treatment of primary humoral immunodeficiency, chronic immune thrombocytopenic purpura in patients 15 years of age and older, chronic inflammatory demyelinating polyneuropathy in adults.

Medical 52
article thumbnail

When Will Payers Improve Coverage of Prescription Digital Therapeutics?

PharmExec

New MMIT research highlights payers’ continued hesitancy toward PDTs. Here’s what manufacturers need to know.

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.